Clinical trial
Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis
NCT00318175 · Heinrich-Heine University, Duesseldorf, Other · Completed
Key facts
| NCT number | NCT00318175 |
|---|---|
| Title | Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis |
| Official title | Study to Assess the Effect of Bosentan on the Treatment of Skin Fibrosis in Patients With Systemic Sclerosis (BTSF) |
| Lead sponsor | Heinrich-Heine University, Duesseldorf, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Systemic Scleroderma, Skin Fibrosis, Hand Functionality |
| Intervention type | Drug |
| Interventions | Bosentan (Tracleer) |
| Enrollment | 10 |
| Start date | Jun 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Apr 26, 2006 |
| Last update posted | Sep 10, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: